Molecular Targeting Technologies, Inc.: Clinical Trials

1 trial sponsored by Molecular Targeting Technologies, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Molecular Targeting Technologies, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.
99mTc-glucarate solution - Acute Coronary Syndrome
Phase 2CompletedMolecular Targeting Technologies, Inc.662008-10-012013-10-24

Conditions studied

Acute Coronary Syndrome (1)

Countries

United States (1)

Top investigators

Albert J. Sinusas, MD (1)  ·  Ami E Iskandrian, MD (1)  ·  Diwakar Jain, MD (1)  ·  Prem Soman, MD, Ph.D. (1)  ·  Robert S Jones, MD (1)

NIH funding

R44HL062770 (1)